The University of Chicago Header Logo

Connection

James Siegler to Neuromyelitis Optica

Back to Details
This is a "connection" page, showing publications James Siegler has written about Neuromyelitis Optica.
James Siegler
Connection Strength
0.220
Neuromyelitis Optica
  1. Utilization of FDA approved treatments for neuromyelitis optica spectrum disorder in clinical practice: A survey study of academic neuroimmunologists. Mult Scler Relat Disord. 2023 Dec; 80:105076.
    View in: PubMed
    Score: 0.220
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.